Back to search
FDAFDA · Food and drugs·Recall number D-0074-2018

Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only. Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-390-01

Published November 22, 2017 · Recall initiated: August 29, 2017

Summary

FDA records drug Class III recall D-0074-2018, published November 22, 2017 and initiated August 29, 2017. Recalling firm: Amerisource Health Services; Status: Terminated; Reported quantity: 93,600 tablets; Lot: Lot #:167194; Exp. 12/31/2018. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Stability Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amerisource Health Services
Distributor
Nationwide USA and Puerto Rico
Lot
Lot #:167194; Exp. 12/31/2018
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Enalapril Maleate Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only. Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-390-01 recalled?

Yes. FDA published recall D-0074-2018 on November 22, 2017. Reported hazard: Failed Stability Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter